Comparison of registries of interstitial lung diseases (ILD) in three European countries

M. Thomeer, U. Costabel, G. Rizzato, V. Poletti, M. Demedts (Leuven, Belgium; Essen, Germany; Milano, Bologna, Italy)

Source: Annual Congress 2001 - Asthma and interstitial lung disease
Session: Asthma and interstitial lung disease
Session type: Thematic Poster Session
Number: 2952
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Thomeer, U. Costabel, G. Rizzato, V. Poletti, M. Demedts (Leuven, Belgium; Essen, Germany; Milano, Bologna, Italy). Comparison of registries of interstitial lung diseases (ILD) in three European countries. Eur Respir J 2001; 16: Suppl. 31, 2952

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
Source: ERJ Open Res, 8 (1) 00597-2021; 10.1183/23120541.00597-2021
Year: 2022



Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001



Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020




A national registry for childhood interstitial and diffuse lung diseases in the United States.
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Report on the registration of interstitial lung diseases in Spain
Source: Eur Respir J 2003; 22: Suppl. 45, 198s
Year: 2003

Interstitial lung diseases in Europe
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011

Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Outcomes in interstitial lung diseases (ILDs)
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Central European idiopathic pulmonary fibrosis (IPF) patients survey
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

The utilization pattern of surgical lung biopsies (SLB) for the diagnosis of interstitial lung diseases (ILD) in Sri Lanka
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Chronic respiratory diseases and lung cancer research: a perspective from the European Union
Source: Eur Respir J 2015; 46: 1270-1280
Year: 2015


Respiratory medication use, lung function, and prior diagnosis of obstructive lung disease in five Latin American cities: the PLATINO study
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008


The burden of lung disease in Europe: why a European White Book on lung disease?
Source: Eur Respir J 2003 Dec 01;22(6):869
Year: 2003


Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Interstitial lung diseases in children: The French national cohort study
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011